The revenue stands at ₹16,198.71 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.87 per cent from ₹15,299.88 crore. This corresponds to a year-on-year *(YoY) growth of 11.88 per cent.
Operating Profit stands at ₹3,475.06 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.53 per cent from ₹4,213.58 crore. This corresponds to a year-on-year *(YoY) decline of 23.24 per cent.
PBDT stands at ₹3,911.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.99 per cent from ₹4,827.96 crore. This corresponds to a year-on-year *(YoY) decline of 19.93 per cent.
Profit Before Tax stands at ₹3,152.86 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 22.90 per cent from ₹4,089.24 crore. This corresponds to a year-on-year *(YoY) decline of 24.13 per cent.
Net Profit stands at ₹1,995.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.23 per cent from ₹2,901.23 crore. This represents a 36.16 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | 1.64% | 1.17% | 9.05% | 0.11% | 1.20% | 7.04% |
| Divi's Lab. | 0.98% | -2.71% | 22.16% | 30.17% | 62.16% | 72.93% |
| Torrent Pharma. | -0.47% | -0.99% | 1.95% | -7.59% | 4.20% | 24.16% |
| Laurus Labs | -0.86% | -4.88% | 14.41% | 26.28% | 69.10% | 133.18% |
Chairman / Executive Director / M D / Promoter : Dilip S Shanghvi
Executive Director & MD : Kirti Wardhaman Ganorkar
Lead Independent Non Executive Director : Pawan Goenka
Independent Non Exe. Director : Rolf Hoffmann
ED / WTD / CFO / Promoter : AALOK DILIP SHANGHVI
E D & Wholetime Director : Vidhi Shanghvi
Independent Non Exe. Director : Satyavati Berera
Independent Non Exe. Director : Andreas Busch
Company Sec. & Compli. Officer : ANOOP ANJANIKUMAR DESHPANDE